活化白细胞黏附分子促进过敏性哮喘T细胞反应
本研究在卵清蛋白诱导的野生型与ALCAM缺陷小鼠过敏性哮喘模型中,结合树突状细胞共培养与过继转移实验,发现ALCAM通过刺激T细胞活化与增殖促进过敏性哮喘炎症,抗ALCAM抗体可减轻炎症反应,哮喘患儿痰和血清ALCAM浓度高于对照。
要点
- ALCAM缺陷小鼠过敏性炎症反应低于野生型小鼠
- 抗ALCAM抗体治疗可减轻小鼠炎症反应
- 哮喘患儿痰与血清ALCAM浓度高于对照,提示其作为治疗靶点的潜力
核心结论
- ALCAM通过刺激T细胞活化与增殖参与卵清蛋白诱导的过敏性哮喘,提示其可能成为过敏性哮喘的潜在治疗靶点。
研究设计与样本
- 在野生型(WT)与ALCAM缺陷(ALCAM-/-)小鼠中建立卵清蛋白(OVA)诱导的过敏性哮喘模型。
- 与树突状细胞(DCs)共培养评估T细胞增殖,并将WT与ALCAM-/-小鼠骨髓来源树突状细胞(BMDCs)过继转移至OT-II小鼠进行OVA致敏或激发。
- 给予抗ALCAM抗体评估治疗潜力,并用ELISA定量哮喘患儿痰与血清ALCAM浓度。
主要发现
- ALCAM-/-小鼠炎症反应低于WT小鼠。
- 与ALCAM-/-小鼠DCs共培养的T细胞增殖较与WT小鼠DCs共培养者减少。
- 过继转移ALCAM-/-小鼠BMDCs后炎症反应较转移WT小鼠BMDCs者降低。
- 抗ALCAM抗体处理小鼠炎症反应减轻。
- 哮喘患儿痰和血清ALCAM浓度高于对照受试者。
临床怎么用
- 研究提示ALCAM可能作为过敏性哮喘的潜在治疗靶点,抗ALCAM抗体在动物模型中显示减轻炎症的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: The activated leukocyte cell adhesion molecule (ALCAM) is a cluster of differentiation 6 ligand that is important for stabilizing the immunological synapse and inducing T-cell activation and proliferation. OBJECTIVES: In this study, we investigated the role of ALCAM in the development of inflammation in allergic asthma. METHODS: An ovalbumin (OVA)-induced allergic asthma model was established in wild-type (WT) and ALCAM-deficient (ALCAM-/-) mice. T-cell proliferation was evaluated in cocultures with dendritic cells (DCs). Bone marrow-derived dendritic cells (BMDCs) from WT and ALCAM-/- mice were cultured and adoptively transferred to OT-II mice for either OVA sensitization or challenge. An anti-ALCAM antibody was administered to assess its therapeutic potential. ALCAM concentrations in the sputum and serum of children with asthma were quantified by ELISA. MEASUREMENTS AND MAIN RESULTS: Inflammatory responses were lower in ALCAM-/- mice than in WT mice, and T cells cocultured with DCs from ALCAM-/- mice showed reduced proliferation relative to those cocultured with DCs from WT mice. A decreased inflammatory response was observed upon adoptive transfer of BMDCs from ALCAM-/- mice as compared with that observed after transfer of BMDCs from WT mice. In addition, anti-ALCAM antibody-treated mice showed a reduced inflammatory response, and sputum and serum ALCAM concentrations were higher in children with asthma than in control subjects. CONCLUSIONS: ALCAM contributes to OVA-induced allergic asthma by stimulating T-cell activation and proliferation, suggesting it as a potential therapeutic target for allergic asthma.
引用
- Kim MN, Hong JY, Shim DH, et al. Activated Leukocyte Cell Adhesion Molecule Stimulates the T-Cell Response in Allergic Asthma. Am J Respir Crit Care Med. 2018. PMID: 29394080. doi:10.1164/rccm.201703-0532OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。